Eduard Stange

Robert Bosch Krankenhaus, Stuttgart, Germany

Eduard F. Stange

Academic positions:
- Professor of Medicine
- Chief of the Department of Internal Medicine

All industry positions (in last five years):

Research interests:
Basic research on antibiotic peptides in inflammatory bowel diseases, improvement of immunosuppressive strategies and development of guidelines for the German Society for Digestive and Metabolic Disorders.

Any other information:
Memberships: Deutsche Gesellschaft für Verdauungs- und Stoffwechselkrankheiten, Deutsche Gesellschaft für Innere Medizin, International Organisation for Inflammatory Bowel Diseases, European Crohn´s and Colitis Organisation.

Any competing interests declared are displayed with individual evaluations.

Faculty Member: Gastroenterology & Hepatology > Inflammatory Bowel Disease (since 07 April 2006)

All recent recommendations

• 6.4
  XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease.
  Recommended by Tor Savidge, Eduard Stange
  
• 3.0
  Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease.
  Recommended by Eduard Stange
  
• 3.0
  Pneumocystis jiroveci (carinii) pneumonia after infliximab therapy: a review of 84 cases.
  Recommended by Eduard Stange
  
• 3.0
  Developmental switch of intestinal antimicrobial peptide expression.
  Recommended by Eduard Stange
  
• 3.3
  Phosphatidylcholine for steroid-refractory chronic ulcerative colitis: a randomized trial.
  Recommended by Eduard Stange, Paul Pavli, Russell Cohen
  
• 9.0
  Gene-specific control of inflammation by TLR-induced chromatin modifications.
  Recommended by Eduard Stange
  
• 3.4
  Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease.
  Recommended by Jon Markowitz, Eduard Stange, Piero Vernia, William Berquist with Anita Talisetti
  
• 4.8
  Epithelial NEMO links innate immunity to chronic intestinal inflammation.
  Recommended by Eduard Stange, Michael McDermott with Dr Michael Sprakes
  
• 6.5
  A genome-wide association study identifies IL23R as an inflammatory bowel disease gene.
  Recommended by Jack Satsangi, Eduard Stange, Lars Rogge
  
• 6.0
  Symbiotic bacteria direct expression of an intestinal bactericidal lectin.
  Recommended by Eduard Stange
  
• 3.0
  Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease.
  Recommended by Eduard Stange
  
• 3.0
  A randomised, dose-finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis.
  Recommended by Eduard Stange